Pediatr Emerg Med J.  2022 Jun;9(1):44-47. 10.22470/pemj.2022.00458.

Clinical experience of hemoperfusion treatment in children with paraquat poisoning

Affiliations
  • 1Department of Pediatrics, Kyungpook National University Hospital, Daegu, Republic of Korea
  • 2Department of Pediatrics, Busan Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea

Abstract

Paraquat is a fatal, rapid-acting, nonselective herbicide. Despite the restriction of production and sales of the herbicide in Korea since 2012, already purchased paraquat can incur poisoning. This article describes a 25-month-old boy who accidentally ingested old paraquat on a rural road. After initial decontamination at 2 outside hospitals, he was transferred to the intensive care unit. Given the urine drug concentration of 20,000 ng/mL 2 hours after the intoxication, he received charcoal hemoperfusion and continuous venovenous hemofiltration to enhance the excretion of the herbicide. In 36 hours after intoxication, it was not detected in the urine. The boy was discharged uneventfully on day 8. This case highlights the importance of hemoperfusion in paraquat poisoning.

Keyword

Accidents; Child; Hemoperfusion; Paraquat; Poisoning

Reference

References

1. Proudfoot AT, Stewart MS, Levitt T, Widdop B. Paraquat poisoning: significance of plasma-paraquat concentrations. Lancet. 1979; 314:330–2.
Article
2. Hong YC, Ryu HH, Lee BG, Moon JM, Chun BJ. Plasma paraquat concentration and the severity index of paraquat poisoning (SIPP) at presentation in paraquat intoxication. J Korean Soc Emerg Med. 2008; 19:513–20. Korean.
3. Scherrmann JM, Houze P, Bismuth C, Bourdon R. Prognostic value of plasma and urine paraquat concentration. Hum Toxicol. 1987; 6:91–3.
Article
4. Jones GM, Vale JA. Mechanisms of toxicity, clinical features, and management of diquat poisoning: a review. J Toxicol Clin Toxicol. 2000; 38:123–8.
Article
5. Hsieh YW, Lin JL, Lee SY, Weng CH, Yang HY, Liu SH, et al. Paraquat poisoning in pediatric patients. Pediatr Emerg Care. 2013; 29:487–91.
Article
6. Qiu L, Deng Y. Paraquat poisoning in children: a 5-year review. Pediatr Emerg Care. 2021; 37:e846–9.
7. Senarathna L, Eddleston M, Wilks MF, Woollen BH, Tomenson JA, Roberts DM, et al. Prediction of outcome after paraquat poisoning by measurement of the plasma paraquat concentration. QJM. 2009; 102:251–9.
Article
8. Wang Y, Chen Y, Mao L, Zhao G, Hong G, Li M, et al. Effects of hemoperfusion and continuous renal replacement therapy on patient survival following paraquat poisoning. PLoS One. 2017; 12:e0181207.
Article
9. Houze P, Baud FJ, Mouy R, Bismuth C, Bourdon R, Scherrmann JM. Toxicokinetics of paraquat in humans. Hum Exp Toxicol. 1990; 9:5–12.
Article
10. Choi WS, Jung EH, Park EH, Seo JY, Jun KH, Kang MS, et al. Usefulness of hemoperfusion in paraquat poisoning. Korean J Med. 2011; 80:308–16. Korean.
11. Hsu CW, Lin JL, Lin-Tan DT, Chen KH, Yen TH, Wu MS, et al. Early hemoperfusion may improve survival of severely paraquat-poisoned patients. PLoS One. 2012; 7:e48397.
Article
12. Li C, Hu D, Xue W, Li X, Wang Z, Ai Z, et al. Treatment outcome of combined continuous venovenous hemofiltration and hemoperfusion in acute paraquat poisoning: a prospective controlled trial. Crit Care Med. 2018; 46:100–7.
13. Wu WP, Lai MN, Lin CH, Li YF, Lin CY, Wu MJ. Addition of immunosuppressive treatment to hemoperfusion is associated with improved survival after paraquat poisoning: a nationwide study. PLoS One. 2014; 9:e87568.
Article
Full Text Links
  • PEMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr